|
6-Hydroxy Palonosetron
|
帕洛諾司瓊6-羥基雜質(zhì)
|
|
|
(R,S)-Palonosetron Acid Hydrochloride
|
RS-帕洛諾司瓊酸（鹽酸鹽）
|
|
|
(6S)-Hydroxy (R,S)-Palonosetron
|
RS-帕洛諾司瓊6S-羥基雜質(zhì)
|
|
|
Palonosetron Impurity 8
|
帕洛諾司瓊雜質(zhì)8
|
177793-80-5
|
|
(6R)-Hydroxy (R,S)-Palonosetron
|
RS-帕洛諾司瓊6R-羥基雜質(zhì)
|
175873-26-4
|
|
(6S)-Hydroxy Palonosetron
|
帕洛諾司瓊6S-羥基雜質(zhì)
|
848074-08-8
|
|
Palonosetron USP Related Compound B
|
帕洛諾司瓊USP雜質(zhì)B
|
1021456-82-5
|
|
(6R)-Hydroxy Palonosetron
|
帕洛諾司瓊6R-羥基雜質(zhì)
|
176019-33-3
|
|
Palonosetron Impurity 4
|
帕洛諾司瓊雜質(zhì)4
|
177793-79-2
|
|
Trelagliptin Impurity 3
|
曲格列汀雜質(zhì)3
|
|
|
Trelagliptin Impurity 2
|
曲格列汀雜質(zhì)2
|
|
|
Trelagliptin Impurity 4
|
曲格列汀雜質(zhì)4
|
|
|
Apixaban Impurity
|
阿哌沙班雜質(zhì)
|
1686149-74-5
|
|
Apixaban Impurity
|
阿哌沙班雜質(zhì)
|
1998079-11-0
|
|
6-Oxo-Palonosetron
|
帕洛諾司瓊6-羰基雜質(zhì)
|
848074-10-2
|
|
Trelagliptin Impurity 1
|
曲格列汀雜質(zhì)1
|
1821400-07-0
|
|
Gefitinib Impurity 22
|
吉非替尼雜質(zhì)22
|
1608115-59-8
|
|
Gefitinib Impurity 23
|
吉非替尼雜質(zhì)23
|
675126-28-0
|
|
Gefitinib Impurity 24
|
吉非替尼雜質(zhì)24
|
194423-17-1
|
|
Gefitinib Impurity 25
|
吉非替尼雜質(zhì)25
|
675126-27-9
|
|
Acebutolol Impurity 1
|
醋丁洛爾雜質(zhì)A
|
28197-66-2
|
|
Acebutolol Impurity 2
|
醋丁洛爾雜質(zhì)B
|
22568-64-5
|
|
Acebutolol Impurity 3
|
醋丁洛爾雜質(zhì)C
|
40188-45-2
|
|
Acebutolol Impurity 4
|
醋丁洛爾雜質(zhì)D
|
57898-80-3
|
|
Acebutolol Impurity 6
|
醋丁洛爾雜質(zhì)F
|
96480-91-0
|
|
Acebutolol Impurity 7
|
醋丁洛爾雜質(zhì)G
|
1330165-98-4
|
|
Acebutolol Impurity 8
|
醋丁洛爾雜質(zhì)H
|
1329613-31-1
|
|
Acebutolol Impurity 9
|
醋丁洛爾雜質(zhì)I
|
441019-91-6
|
|
Acebutolol Impurity 11
|
醋丁洛爾雜質(zhì)K
|
57898-71-2
|
|
Imatinib Impurity 12
|
伊馬替尼雜質(zhì)12
|
404844-11-7
|
|
Gefitinib Impurity 19
|
吉非替尼雜質(zhì)19
|
1603814-04-5
|
|
Gefitinib Impurity 11
|
吉非替尼雜質(zhì)11
|
847949-50-2
|
|
Gefitinib Impurity 10
|
吉非替尼雜質(zhì)10
|
847949-56-8
|
|
Gefitinib Impurity 13
|
吉非替尼雜質(zhì)13
|
230955-75-6
|
|
Imatinib Impurity 23
|
伊馬替尼雜質(zhì)23
|
180258-54-2
|
|
Imatinib Impurity 20
|
伊馬替尼雜質(zhì)20
|
796738-71-1
|
|
Gefitinib Impurity 14
|
吉非替尼雜質(zhì)14
|
179688-53-0
|
|
Gefitinib Impurity 9
|
吉非替尼雜質(zhì)9
|
847949-49-9
|
|
Imatinib Impurity 19
|
伊馬替尼雜質(zhì)19
|
1407124-83-7
|
|
Imatinib Impurity 21
|
伊馬替尼雜質(zhì)21
|
475587-23-6
|
|
Gefitinib Impurity 20
|
吉非替尼雜質(zhì)20
|
675126-26-8
|
|
Gefitinib Impurity 12
|
吉非替尼雜質(zhì)12
|
153437-78-6
|
|
Imatinib Impurity 18
|
伊馬替尼雜質(zhì)18
|
1802325-93-4
|
|
Gefitinib Impurity 18
|
吉非替尼雜質(zhì)18
|
199327-59-8
|
|
Gefitinib Impurity 17
|
吉非替尼雜質(zhì)17
|
246512-44-7
|
|
Gefitinib Impurity 21
|
吉非替尼雜質(zhì)21
|
179688-52-9
|
|
Gefitinib Impurity 15
|
吉非替尼雜質(zhì)15
|
13794-72-4
|
|
Imatinib Impurity 22
|
伊馬替尼雜質(zhì)22
|
1232063-00-1
|
|
Imatinib Impurity F
|
伊馬替尼雜質(zhì)F
|
152460-10-1
|
|
Imatinib Impurity 16
|
伊馬替尼雜質(zhì)16
|
581076-64-4
|
|
Imatinib Impurity 15
|
伊馬替尼雜質(zhì)15
|
152459-96-6
|
|
Imatinib Impurity 13
|
伊馬替尼雜質(zhì)13
|
152460-09-8
|
|
Afatinib Impurity 7
|
阿法替尼雜質(zhì)12
|
179552-74-0
|
|
Afatinib N-Oxide
|
阿法替尼雜質(zhì)18（氮氧化物）
|
2413212-11-8
|
|
Afatinib Impurity J
|
阿法替尼雜質(zhì)10（雜質(zhì)J）
|
1456696-14-2
|
|
Afatinib Impurity 1
|
阿法替尼雜質(zhì)1
|
402855-07-6
|
|
Afatinib Impurity 6
|
阿法替尼雜質(zhì)11
|
2512206-82-3
|
|
Afatinib Impurity 19
|
阿法替尼雜質(zhì)36
|
2475095-57-7
|
|
Afatinib Impurity 15
|
阿法替尼雜質(zhì)31
|
162012-70-6
|
|
Afatinib Impurity 16
|
阿法替尼雜質(zhì)33
|
2475095-50-0
|
|
Afatinib Impurity 21
|
阿法替尼雜質(zhì)38
|
2414260-31-2
|
|
Afatinib Impurity 12
|
阿法替尼雜質(zhì)27
|
2413212-25-4
|
|
Afatinib Impurity 11
|
阿法替尼雜質(zhì)25
|
2223677-60-7
|
|
Afatinib Impurity 18
|
阿法替尼雜質(zhì)35
|
2475095-54-4
|
|
Gefitinib Impurity 16
|
吉非替尼雜質(zhì)16
|
788136-89-0
|
|
Gefitinib Impurity 26
|
吉非替尼雜質(zhì)26
|
193552-54-4
|
|
Palonosetron USP Related Compound E
|
帕洛諾司瓊USP雜質(zhì)E
|
135729-55-4
|
|
(R,S)-Palonosetron N-Oxide
|
RS-帕洛諾司瓊氮氧化物
|
|
|
Afatinib Impurity 13
|
阿法替尼雜質(zhì)29
|
1957132-02-3
|
|
Afatinib Impurity 20
|
阿法替尼雜質(zhì)37
|
2475095-58-8
|
|
Afatinib Impurity K
|
阿法替尼雜質(zhì)19（雜質(zhì)K）
|
2413212-13-0
|
|
Afatinib Impurity 17
|
阿法替尼雜質(zhì)34
|
2475095-51-1
|
|
Afatinib Impurity 22
|
阿法替尼雜質(zhì)39
|
2223677-58-3
|
|
Afatinib Impurity 24
|
阿法替尼雜質(zhì)41
|
2348580-72-1
|
|
Afatinib Impurity 25
|
阿法替尼雜質(zhì)42
|
314771-88-5
|
|
Afatinib Impurity 23
|
阿法替尼雜質(zhì)40
|
1259015-90-1
|
|
Adefovir Dipivoxyl Impurity 18
|
阿德福韋酯雜質(zhì)18
|
1538-75-6
|
|
Adefovir Dipivoxyl Impurity 14
|
阿德福韋酯雜質(zhì)14
|
91240-66-3
|
|
Adefovir Dipivoxyl Impurity 1
|
阿德福韋酯雜質(zhì)1
|
1215101-40-8
|
|
Adefovir Dipivoxyl Impurity 10
|
阿德福韋酯雜質(zhì)10
|
1875153-79-9
|
|
Adefovir Dipivoxyl Impurity 15
|
阿德福韋酯雜質(zhì)15
|
4551-95-5
|
|
Adefovir Dipivoxyl Impurity 3
|
阿德福韋酯雜質(zhì)3
|
323201-06-5
|
|
Adefovir Dipivoxyl Impurity C
|
阿德福韋酯雜質(zhì)C
|
142341-04-6
|
|
Adefovir Dipivoxyl Impurity A
|
阿德福韋酯雜質(zhì)A
|
142341-05-7
|
|
Adefovir Dipivoxyl Impurity B
|
阿德福韋酯雜質(zhì)B
|
323201-05-4
|
|
Adefovir Dipivoxyl Impurity 12
|
阿德福韋酯雜質(zhì)12
|
96-49-1
|
|
Adefovir Dipivoxyl Impurity I
|
阿德福韋酯雜質(zhì)I
|
323201-04-3
|
|
Adefovir Dipivoxyl Impurity 2
|
阿德福韋酯雜質(zhì)2
|
1416439-02-5
|
|
Adefovir Dipivoxyl Impurity 13
|
阿德福韋酯雜質(zhì)13
|
20245-85-6
|
|
Adefovir Dipivoxyl Impurity E
|
阿德福韋酯雜質(zhì)19（雜質(zhì)E）
|
116384-54-4
|
|
Imatinib Impurity 8
|
伊馬替尼雜質(zhì)8
|
571186-93-1
|
|
Imatinib Impurity 7
|
伊馬替尼雜質(zhì)7
|
571186-92-0
|
|
Imatinib EP Impurity J
|
伊馬替尼雜質(zhì)J
|
571186-91-9
|
|
Afatinib Impurity 27
|
阿法替尼雜質(zhì)44
|
2323570-72-3
|
|
Afatinib Impurity 29
|
阿法替尼雜質(zhì)46
|
1449430-45-8
|
|
Afatinib Impurity 26
|
阿法替尼雜質(zhì)43
|
162012-69-3
|
|
Afatinib Impurity 28
|
阿法替尼雜質(zhì)45
|
618061-76-0
|
|
Imatinib Impurity 11
|
伊馬替尼雜質(zhì)11
|
1246819-59-9
|
|
Imatinib Impurity 10
|
伊馬替尼雜質(zhì)10
|
1365802-18-1
|
|
Imatinib Impurity 9
|
伊馬替尼雜質(zhì)9
|
938082-57-6
|